However, a recent study of pancreatic cancer showed that metformin at low concentrations selectively inhibited the proliferation and the invasive capacities of CD133+ cells in vitro, and of pancreatic cancer xenograft growth in vivo [21]. Here, PROM1 is linked to pancreatic neoplasm.